The Manila Times

Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to ...

January Issue of the Journal of Cardiac Failure Highlights Prevention, Innovation, and New Strategies to Improve Outcomes Across the Heart Failure Spectrum

A novel approach to removing excess fluid through the skin and a new strategy to prevent right ventricular failure after LVAD ...
Medscape

Beta-Blockers After MI May Not Offer Much in Preserved EF

A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in ...

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 ...